8-phenyltheophylline has been researched along with Obesity in 2 studies
8-phenyltheophylline: purinergic P1 receptor antagonist
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Challis, RA | 1 |
Budohoski, L | 1 |
McManus, B | 1 |
Newsholme, EA | 1 |
Vannucci, SJ | 1 |
Klim, CM | 1 |
Martin, LF | 1 |
LaNoue, KF | 1 |
2 other studies available for 8-phenyltheophylline and Obesity
Article | Year |
---|---|
Effects of an adenosine-receptor antagonist on insulin-resistance in soleus muscle from obese Zucker rats.
Topics: Animals; Glycogen; Glycolysis; In Vitro Techniques; Insulin; Lactates; Lactic Acid; Male; Muscles; O | 1984 |
A1-adenosine receptor-mediated inhibition of adipocyte adenylate cyclase and lipolysis in Zucker rats.
Topics: Adenosine; Adenosine Deaminase; Adenylate Cyclase Toxin; Adenylyl Cyclase Inhibitors; Adipose Tissue | 1989 |